HEOR stakeholder

What is an HEOR stakeholder?

An HEOR stakeholder is an individual, group or organisation that uses, assesses or influences health economics and outcomes research when making healthcare decisions. HEOR stakeholders include payers, health technology assessment agencies, policymakers and academic researchers evaluating the cost, value and impact of medical products and services.

They use evidence such as economic evaluations, patient and clinical outcomes, real-world evidence and comparative studies to inform pricing, reimbursement, coverage, policy and treatment adoption. Their remit and influence vary by healthcare system, institution and decision context.

Why do HEOR stakeholders matter in HEOR and market access?

HEOR stakeholders help determine whether an evidence package is relevant and credible for the decision it is intended to support. Their requirements affect which comparators, populations, outcomes, time horizons and economic assumptions a pharmaceutical team should address.

Early, appropriate engagement can reveal evidence gaps before analyses are finalised or studies are difficult to change. This helps align evidence generation with payer and assessment expectations, supports market access planning and reduces the risk that a submission answers the wrong question. Stakeholders remain independent decision-makers rather than partners expected to endorse a product.

How are HEOR stakeholders identified and engaged in practice?

Teams begin by defining the decision, geography and stage of the product lifecycle. They then map the organisations and roles that can set evidence requirements, assess value, influence policy or apply findings in practice. Prioritisation should reflect decision authority, subject expertise, relevance to the population and the timing of likely input.

Engagement may include payer research, advisory boards, scientific advice, interviews, evidence-generation collaborations or discussion at scientific meetings. The format must follow local governance, contracting, transparency and compliance requirements. Teams should document the purpose of each interaction, the questions asked, the advice received and how that advice affects the integrated evidence plan.

What evidence do HEOR stakeholders typically assess?

The evidence depends on the stakeholder and decision, but commonly includes:

• Disease burden, unmet need and the characteristics of the relevant patient population.
• Clinical outcomes, safety, quality of life and other patient-relevant outcomes.
• Resource use, costs, budget impact and affordability.
• Comparative effectiveness against treatments used in the relevant setting.
• Economic analyses that estimate costs and outcomes over an appropriate period.
• Real-world studies used to describe care pathways, validate assumptions or address uncertainty.

A payer may focus on budget consequences and eligible population size, while an assessment body may scrutinise comparator choice and model assumptions. Academic researchers may focus more closely on methods, bias and reproducibility. The same evidence package therefore needs a consistent core argument with adaptations for legitimate local requirements.

Who owns HEOR stakeholder engagement, and where do teams go wrong?

Ownership is usually shared across HEOR, market access, medical affairs, epidemiology and other evidence functions. Global teams may establish the core strategy, while regional and affiliate teams provide knowledge of local decision processes and relationships. Clear responsibilities are needed for stakeholder mapping, contact, insight capture, evidence changes and follow-up.

Common mistakes include treating all payers or assessment bodies as one audience, engaging only after the evidence plan is fixed, asking broad questions that cannot guide a decision, and collecting insights without recording their implications. Teams can also overreact to one opinion. Stakeholder input should be assessed alongside published methods, formal requirements, internal expertise and input from other relevant decision-makers.

How is an HEOR stakeholder different from related HEOR terms?

An HEOR stakeholder is the person or organisation using, evaluating or influencing the research. HEOR is the broader discipline that examines the economic and health outcomes of interventions. An economic model, real-world study or value dossier is an evidence asset that a stakeholder may assess; it is not itself a stakeholder.

The term is also narrower than healthcare stakeholder, which can include anyone affected by healthcare delivery. A person becomes relevant as an HEOR stakeholder when their role connects directly to questions of outcomes, comparative value, costs, reimbursement, policy or evidence methods.